Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Goodwin order book hits £300m, shares jump

(Sharecast News) - Shares in Goodwin sparked on Wednesday, after the engineering specialist's order book hit a record high. The group, which owns various mechanical and refractory engineering companies, said the order book had reached £300m as at February end, leaving it on track to deliver second-half profits comparable to those in the first half.

As at 1145 GMT, shares in the FTSE 250 stock had put on 5% at 7,200p.

Driving the growth was Noreva, Goodwin's Germany-based specialist nozzle check valve company. It won a two-year $15m contract to supply valves for an LNG project, the largest in Noreva's history.

Timothy Goodwin, chair of the family-run group, said: "This contract positions us well to benefit from the expected release of further LNG projects, in light of the growing global demand for LNG.

"The board is delighted with the group's performance, and the strategic positioning we have achieved. With our record order book, expanding capabilities and strong financial foundation, we are well-placed to sustain our success and drive further growth in profitability."

Goodwin, which was founded in Stoke-on-Trent in 1883 as R Goodwin & Sons, is due to publish results for the year to April end in August.

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.